By Jennifer Chiou
New York, Aug. 8 - MAKO Surgical Corp. said it closed a series B round of financing for $20 million.
MDS Capital led investors that included The Exxel Group, Aperture Venture Partners, MediTech Advisors, Ivy Capital Partners and Sycamore Ventures.
"We are excited to welcome such a high caliber group of investors with extensive experience in the health care sector to the MAKO team," said MAKO president and chief executive officer Maurice R. Ferre in a news release.
"Given the significant increase in aging population, active life style patients who are looking for alternative solutions to a long hospital stay and a long rehabilitation period will significantly benefit from Makoplasty."
The Hollywood, Fla., medical technology company will use the proceeds to complete the development of its products and establish its initial clinical sites.
MAKO, which is focused on knee replacement medical devices, has Makoplasty for rapid patient recovery and improved anatomical functionality.
| Issuer: | MAKO Surgical Corp.
|
| Issue: | Preferred stock
|
| Amount: | $20 million
|
| Round: | Series B
|
| Investors: | MDS Capital (lead), The Exxel Group, Aperture Venture Partners, MediTech Advisors, Ivy Capital Partners, Sycamore Ventures
|
| Announcement date: | Aug. 8
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
